FI81359B - GLYKOSIDER AV RESORUFIN-DERIVAT, FOERFARANDE FOER FRAMSTAELLNING DAERAV SAMT DERAS ANVAENDNING FOER BESTAEMNING AV AKTIVITETEN AV GLYKOSIDASER. - Google Patents

Abstract

The glycosides of resorufin derivatives have the general formulae Ia and Ib <IMAGE> in which R<1> is hydrogen, R<2>, R<3> and R<5>, which can be identical or different, are hydrogen, halogen or a lower alkyl group, R<4> and R<6>, which can be identical or different, are hydrogen, halogen, a cyano, lower alkyl, lower alkoxy, carboxyl, lower alkoxycarbonyl, carboxy-lower alkyl, lower alkoxycarbonyl-lower alkyl or an optionally mono- or disubstituted carboxamide group or the group -COO-(CH2CH2O)n-R<7> in which R<7> is hydrogen or a lower alkyl group and n is an integer from 1 to 4, where R<6> can additionally be a sulphonyl or nitro group, and Y is a nitrogen or the group NO. These compounds are particularly suitable as chromogenic and fluorogenic substrates for determining the activity of corresponding glycosidases or oligosaccharide-cleaving enzymes. The glycosides are obtained by reacting resorufin derivatives with a mono- or oligosaccharide or a 1-halogeno derivative thereof, whose hydroxyl groups are substituted by customary protective groups. This initially results in per-O-substituted glycosides, which can be converted into the claimed compounds by elimination of the protective groups. The glycosides are used as chromogenic and fluorogenic substrates in diagnostic agents for detecting glycosidases or oligosaccharide-cleaving enzymes. The resorufin derivatives employed as starting materials in the preparation of the compounds are also claimed.

Description

1 81359

Glycosides of resorufin derivatives, method for their preparation and their use for the determination of glycosidase activity

Glycosidases have many physiological functions in human and animal organisms. Thus, for example, 3-D-galactosidase is important in carbohydrate metabolism because it mediates the hydrolysis of lactose. In addition, β-D-galactosidase acts as a key enzyme in the degradation of qlycolipids, mucolysaccharides, and qlycoproteins. Other physiologically significant glycosidases include α-D-galactosidase, α-D- and 3-D-q lockase i, and α-D-mannosidase i.

In addition to its physiological importance, the importance of glycosidases has increased in recent years in diagnostics and biotechnology.

Thus, these enzymes are increasingly used, for example, as indicator enzymes in enzymatic immunoassays. Particularly popular in this connection is 3-D-Galactos idaase i / See, for example, Annals of Clinical Biochemistry 1, 6, 221-240 (1979 ^ 7- 7. Thus, the determination of glycosidase activity plays an increasingly important role in both clinical chemistry and diagnostics. this substrate is cleaved by an enzyme.One of these pi 1 kkoonturnis products is appropriately detected.Glycone or aglycone released by either enzyme can be measured.Usually the latter is determined.

Natural substrates for the enzyme to be determined are usually suitable substrates. However, glycosides are particularly preferred because the aglycone therein is an electroscopically readily detectable residue.

2,81359

A number of glycosidase substrates are known from which the aglycone released from the substrates, after cleavage by glycosidase, can be measured at wavelengths of spectroscopically visible light or UV range, as well as fluorometrically.

Thus, Biochem. Z. 333, 209 (1960) describes phenyl-β-D-galactoside as substrates for β-D-galactosidase as well as some other aromatic ring substituted derivatives (such as o-nitrophenyl and β-nitrophenyl-β-D-galactoside). The phenols released in the hydrolysis are determined photometrically in the UV range or, in the case of nitrophenols, at short wavelengths in the visible light range. In this context, oxidative coupling to the amino acid t ipy r i in i in / Analytical Biochem can also be used as an indicator reaction. 40, 281 (1971) 7.

Naphthyl-β-D-calactosides, such as the 1-naphthyl compound, are used in hi-chemistry studies according to Histochemie 3, 5, 199 (1973). The 6-bromo-2-naphthyl derivative of J. Biol. Chem. 195, 239 (1952) or naphthol-β-D-galactoside according to / Histochemie 37, 89 (1973-7) .The resulting naphthols are visualized by converting them to azo dyes with various diazonium salts.

Determination of enzyme activities using fluorogenic substrates is very common because the sensitivity of fluorometric assays is a few tenths of a potency better than photometric methods. In many cases, it is necessary to work with flucrogenic substrates, for example by automated determination of the enzyme activity of cells to distinguish between specialized cells (cytofluorometry) and by analysis of immobilized enzymes by flow microfluorometry. In other cases, for example, in the determination of enzymatic markers (enzymatic immunoassays) in experimental systems, the multiplier effect of enzymatic catalysis is substantially enhanced by the use of fluorogenic substrates.

3 81,359 Fluorogenic substrates known to date for 8-D-galactosidase and other glycosidases contain fluorescein, indoxyl or methylumbelferone derivatives as fluorophores. However, from the point of view of kinetic analysis of complex systems, these compounds have considerable disadvantages. Disubstituted fluorescein derivatives are hydrolyzed in a multi-step reaction sequence. Monosubstituted fluorescein glycosides already fluoresce by themselves. After their enzymatic splicing, the indoxyl derivatives undergo several chemical changes that also complicate such a kinetic analysis. Derivatives of methylumbelliferone must be activated by UV radiation. In this case, the inherent fluorescence of biological or synthetic materials may be interfering. In addition, UV activation, especially when using laser optics, is expensive. Most such fluorogenic substrates result in reaction products that are only sparingly soluble, so they are not suitable for kinetic analysis of enzyme activities, where the name itself requires good solubility of the substrate and product.

Thus, there remained a need to find substrates with which various glycosidases can be determined in a simple, rapid, and reliable manner, and which can potentially be used in both photometric and fluorometric assays. The object of the present invention was to satisfy this need.

The solution to this problem is the novel glycosides of resorufin derivatives, which can be cleaved by glycosidases into the sugar component and the resorufin derivative. The latter are highly water-soluble compounds whose visible light absorption is well measurable and which, moreover, can be easily activated to fluoresce.

Accordingly, this invention relates to glycosides of resorufin derivatives of general formula Ia or Ib 7 r1 R6

WvV5 I Ia

Glycoside-0 R3 R4 R1 R6 'Y / r5 l] h ib

^ O

0 1 i O-Glycoside R3 R4 where R3 is hydrogen 2 3 5 R, R and RJ, which may be the same or different, denote hydrogen, halogen or a lower alkyl group, 4 6 * R and R, which may be the same or different, denote hydrogen, halogen, cyano group, lower alkyl group, lower alkoxy group, carboxy group, lower alkoxycarbonyl group, lower carboxy1kyl group, lower alkoxycarbonyl-lower alkyl group or optionally mono- or doubly substituted carboxyamide group, 2 n wherein R7 represents hydrogen or a lower alkyl group and n represents a total of 1 to 4, in which case it may additionally represent a sulfonyl or nitro group, and Y represents a nitrogen or a group N -> 0.

n 5 81 359

The glycosides of the resorufin derivatives of the general formula I are novel compounds. They can be prepared from carbohydrate chemistry by methods known per se.

R1 R6 r2 Λ v 1 f j I Ia \ o - H0 I T b R1 R6 i3 R4 1 r5 x I X iib of the general tautomeric formulas Ha and Ilb

0 OH

The resorufin derivatives according to R3, R4, wherein R1-R4 and γ have the meanings given above, are preferably converted in a manner known per se with a mono- or oligosaccharide or one of their 1-halo derivatives, in each case all hydroxy groups being substituted by a per-protecting group in carbohydrate chemistry. -substituted glycosides from which glycosides of the resorufin derivatives of the general formula I are obtained by deprotection in a manner known per se.

The conversion of compounds of formula II with oer-O-substituted 1-halosaccharides is preferably carried out in the presence of acid-increasing compounds such as alkali metal hydroxide or carbonate, in aqueous acetone or (under phase transfer conditions) in water / benzene or water / chloroform. in the mixture.

In addition, this process can be carried out by first converting the derivatives of general formula TI into alkali metal salts with alkali hydroxide or alcoholate or ammonium salts with optionally substituted amines, which are then dipolarly converted in aprotic solvents such as acetone, dimethyl sulfoxide, dimethyl sulfoxide, dimethyl sulfoxide in dimethylformamide, with per-O-substituted 1-halosaccharide.

Furthermore, in the synthesis of per-O-substituted glycosides from resorufin derivatives of the formula II and per-O-substituted 1-halosaccharides, mixtures of individual silver salts or mixtures of silver salts (silver oxide, carbonate, celite surface silver carbonate, silver triflate, silver triflate) Additions of individual mercury salts or mixtures of mercury salts (mercuric bromide, cyanide, acetate, oxide) have proven useful, possibly using desiccants such as calcium chloride, molecular sieve or drierite, and in a solvent such as in methylene chloride, chloroform, benzene, toluene or dioxane. To synthesize α-glycosylated glycosides, a compound of general formula II is conveniently melted with a saccharide whose hydroxy groups of the saccharide are substituted with a protecting group, particularly preferably an acetyl group, in the presence of a Lewis acid such as stannous tetrachloride, aluminum chloride, preferably / compare Chem. Ber. 6_6, 378-383 (1933) and Methods in Carbohydr. Chem. 2_, 345-347 (19 6 7 / In this case, the temperature is selected between £ 0 and 150 ° C, preferably between 110 and 130 ° C.

The per-O-substituted glycosides of the resorufin derivatives of general formula II thus obtained are also novel compounds.

Deprotection of per-O-substituted glycosides to glycosides of general formula I is carried out in carbohydrate chemistry according to conventional methods [see, for example, Advances Carbohydrate Chem. 12, 157 (1975)], for example, when the protecting groups are acyl groups, the removal is carried out with sodium methylate or barium methylate or ammonia in methanol.

The invention further relates to the use of resorufin derivatives of general tautomeric formulas IIa and Hb for the preparation of resorufin glycosides of general formulas Ia and Ib.

Symbols rI-R? in the definition, halogen means fluorine, chlorine, bromine or iodine, preferably chlorine or bromine.

The "lower alkyl group" in the definition of the symbols R 1 -R-R 2 has 1 to 5, preferably 1 to 3 carbon atoms, in which case the methyl group is particularly preferred.

The "lower alkoxy group" in the definition of the symbols R 1 and R 2 has 1 to 5, preferably 1 to 3 carbon atoms, in which case a methoxy group is particularly preferred.

The substituents and the lower alkoxycarbonyl and lower carboxyalkyl residue in the definitions and the residue between the lower alkoxycarbonyl and the lower alkyl in the "lower alkoxy residue" and the "lower alkyl residue" also preferably have 1 to 5, preferably 1 to 3 carbon atoms, j residue.

As the "conventional protecting group" in carbohydrate chemistry, an acetyl, benzoyl, benzyl or trimethylsilyl residue is particularly suitable.

Suitable substituents for the carboxamido group are alkyl, alkoxyalkyl, carboxyalkyl and alkoxycarbonylalkyl radicals, these alkyl radicals each having 1 to 5, preferably 1 to 3, carbon atoms. In the case of a doubly substituted carboxamide group, both of these substituents may be enclosed in a ring in which the heteroatom may be, for example, an oxygen atom, a nitrogen atom and a sulfur atom.

8 81 359

Suitable glycoside residues which are bound to the resorufin derivatives of the general formula II to form the glycosides of the general formula I are all those mono- and oligosaccharides which can be released from this resorufin backbone by the corresponding glycosidases. Examples of glycosides according to the invention are: β-D-galactopyranoside, α-D-galactopyranoside, S-D-glucopyranoside, α-D-glucoyranoside and α-D-mannopyranoside.

Also suitable as glycoside residues are oligosaccharide chains which can be broken down by saccharide enzymes into mono- or oligosaccharides, which mono- or oligosaccharides can in turn be cleaved directly from the resorufin backbone with the corresponding glycosides. By such oligosaccharide chains is meant in particular chains formed from 2 to 10, preferably 2 to 7, monosaccharide units.

In addition, this invention is directed to general tautomeric formulas II'a and II 1b

R1 'R6' and II'a O '' VN.

R3 'R4' R1 'R6' O2 'I I R5' [3 · 4 1

R R

9 81359, in which in formulas II'a and II'b the symbols R 1'-R® 'have the same meaning as the substituents R 1 -R 2', in which case, however, the symbols R 1 -R 2 'cannot all mean simultaneously hydrogen, and the symbol Y has the meaning given above, however, at least one of R 1 'and R 10' represents a lower alkoxycarbonyl, optionally mono- or disubstituted carboxamido group or a group -COO- (CH 2 CH 2 O) n R 4 when Y represents nitrogen.

These compounds are new. They are particularly suitable as intermediates in the preparation of the glycosides of the resorufin derivatives according to the invention and the general formula I.

The compounds of the general formula II 'can be prepared analogously to those methods which are suitable for the preparation of known resorufins (a compound of the general formula II in which the symbols R 1 -R 2 in each case denote one hydrogen atom).

The compounds of general formula II 'are preferably prepared in such a way that the compounds of general formula III

R '

R2 / NO

| l I III

HO ^ ^ ^ OH

13.

RJ

The nitrosoresorcin derivatives of the general formula IV are converted into the general formula IV

ίο 81359 R6 'I Iv

ΗΟ / γ ^ ^ OH

I4, where the symbols 1 -6 'R -R have the meaning given above, in the presence of pyrolucite and sulfuric acid at low temperatures. In this case, compounds of the general formula II1 in which Y represents an N -> O group are first formed. These substances can be easily converted into compounds of general formula II ', wherein Y represents nitrogen, with zinc powder in the presence of ammonia.

The reaction between the compounds of general formula lii and the compounds of general formula IV is usually carried out at a temperature in the range of -10 to 50 ° C, preferably in the range of 0 to 30 ° C. This conversion proceeds with particular care if the substances of the general formulas III and IV are mixed together at a temperature of approximately 0 ° C, after which this reaction mixture is allowed to warm to room temperature. The concentration of pyrolucite should suitably be 0.5-5, preferably 1-2 mol / l. The sulfuric acid content should be 0.5 to 5, preferably 1 to 3 mol / l.

The reduction of compounds of general formula II1, wherein Y represents an N-O group, to compounds of general formula II1, wherein Y represents nitrogen, is preferably carried out in a solution containing ammonia on zinc dust / see Nietzki et al., Ber. Dtsch. Chem. Ges. 2_2, 3020 (1889) 7. Suitable solvents are water-alcohol mixtures, preferably a mixture of 1 part of water and 0-4 parts of methanol. 1 to 20, preferably 1 to 5 moles of zinc dust are gradually added per mole of the substance to be reduced. The temperature of the reaction solution 11 81359 is then kept in the range of -10 to 35 ° C, preferably in the range of + 5 to 10 ° C. Staying within this temperature range has proven necessary for the reaction to proceed unambiguously. Without cooling, this exothermic reaction results in by-products that are only difficult to separate.

The conversion reaction between substances of general formula III and general formula IV proceeds unambiguously and in good yield under these selected mild conditions. This selected synthesis route can be converted. Thus, numerous synthetic methods are possible, in particular for the preparation of asymmetrically substituted resorufin or also resazurin derivatives.

In the formula II ', where R4' and / or R6 'denote a lower alkoxycarbonyl group, optionally a carboxylamide group or a -COO- () -R group which is substituted once or twice by 7,

Resorufin derivatives according to formula V are preferably prepared according to general formula V.

R7 "R1 V = o R6" R2 J '5

R. / Int / W / R

o |] | ° v O (yj \ 7 „

R U 4 ”R

R R

wherein 12 3 5 R, R, R and R have the meanings given above, 4 "6" R and R represent a carboxy group and 7 "R represents hydrogen or a lower alkyl group, the corresponding triacylated dihydroresorufins acting as intermediates.

i2 81 359

The carboxylic acid functional group is converted to the acid chloride using methods known in the art, for example by oxalyl chloride / DFM or thionyl chloride / DFM, to give the correspondingly substituted carboxylic acid ester derivatives or carboxamide derivatives by reacting the amide with these acid chlorides.

By treating the acetylated derivatives of general formula ITI thus obtained with a lye, preferably 0.1-5 M sodium or potassium hydroxide, or 1-15 M aqueous ammonia and an oxidizing agent, preferably potassium hexacyanoferrate III, at the same time water-soluble organic solvents such as 1, Addition of 4-dioxane or methanol gives the corresponding resorufin derivatives of general formula II.

In principle, all possible alcohols are suitable as alcohol components. Particularly preferred are diethyl Lg glycol monoethyl ether, triethylene glycol monoethyl ether or simple alcohols such as methanol or ethanol. The amine component can likewise be selected from all possible amines. Particularly preferred are amines having a polar group, such as morpholine, methoxyethylamine or glycinamide or ammonia, a primary or secondary lower alkylamine. In addition, aminocarboxylic acids whose carboxyl group is protected in a conventional manner, such as glycine tert-butyl ester, glycine benzyl ester or Na-BOC-1-lysine methyl ester, can be used. After removal of the protecting groups, resorufin-II or resorufin-glycoside-I having an aliphatic carboxylic acid functional group is thus obtained.

The acetylated dihydroresorufins of the general formula V are obtained from the corresponding resorufin or resazurin by converting them with a strong reducing agent such as tin (II) chloride or chromium (II) acetate or by reducing them electrically with electrically 13 81 359, followed by acetylation. For reduction, resorufin or resazurin is heated for 10 minutes to 1 hour together with 2-10, preferably 2-6 equivalents of stannous chloride in a 5-38% aqueous solution of hydrochloric acid. The dihydro compound precipitates on cooling. The acetylation is carried out in the usual manner with acetic anhydride. The compounds of general formula V are preferably prepared by reductive acetylation using a mixing method. The corresponding resorufin or resazurin is heated under reflux in acetic anhydride together with 2-6 equivalents of stannous chloride for 5 minutes to 5 hours, preferably 10 minutes to 3 hours, or stirred for 4-16 hours.

The synthesis of glycosides of the resorufin derivatives of general formula II yields non-fluorescent compounds from which the fluorescent resorufin derivatives can be further liberated by enzymatic cleavage by the corresponding glycosidases. Compared to the hitherto known glycosides of other chromogenic or fluorogenic groups, the fluorogenic resorufin derivatives according to the invention have very advantageous properties. As monosubstituted derivatives, the kinetics of their enzymatic hydrolysis can be very simply explained by the Michaelis-Menten equation. For example, the Michaelis constant K i of resorufin-β-D-galopyranoside is 0.38 mmol / l. The natural substrate provides competitive inhibition of this hydrolysis, allowing the specific conversion of resorufin-derived glycosides to be determined and altered by the addition of lactose to natural glycosides, such as β-D-galactosidase, for certain studies.

The glycosides of the resorufin derivatives of the invention can be stored in aqueous solution for virtually any length of time at + 4 ° C. The solubility of the resorufin backbone glycosides is already sufficient for most kinetic purposes. The solubility of the corresponding glycosides is substantially improved by the addition of esters of carboxylic acids and derivatives of carboxylic acids having polar groups or sulfonic acid groups.

The radiation activating the products according to the invention and the radiation emitted by these products are in the visible light range of the spectrum when the quantum yield is sufficient. The maximum fluorescence intensity of resorufin is reached at pH values above 7.0 and only attenuates slowly at too low pH values.

The glycosides of this resorufin are usually yellow in color (λ at about 470 nm) in aqueous solution. After the enzymatic reaction, these products are mainly red 7 χ at about 570 nm), so these substances are also excellent for photometric assays and visual methods without measuring devices.

The present invention is further directed to the use of these novel resorufin derivative glycosides of general formula I in the determination of the activity of the corresponding glycosidases, for example α-D- and 2-D-galactosidase, α-D- and β-D-glucosidase and α-D-mannosidase.

Rheorufin derivatives of the general formula I in which the glycosidic residue is an oligosaccharide chain are also particularly suitable for the detection of enzymes which cleave saccharide chains, such as α-amylase. In this case, this oligosaccharide chain is cleaved in a typical manner by the enzyme to be detected, preferably to a monosaccharide, in which case other enzymes can be used as an aid if necessary. This product is then cleaved to the resorufin backbone and monosaccharide using the corresponding glycosidase as described above.

Also within the scope of this invention are novel rangefostic agents containing glycosides of the resorufin derivatives of general formula I which are suitable for the determination of glycosidase activity. The use of these glycosides of the resorufin derivatives of the general formula I as substrates for glycosidases results in clearly more sensitive test systems than in the previous version 81359. These new substrates can be advantageously used to determine the activity of glycosidases in both biochemistry and biotechnology and in the field of clinicochemistry. They are more sensitive, leading to more advantages: a) Lower enzyme activities can be measured.

b) Smaller sample volumes may be used.

c) The determination of activity can be performed in a much shorter time.

(d) The use of smaller sample sizes and the preferred wavelength used for measurement also reduce interference from other components in the sample in this method.

e) The conversion induced by the enzymes immobilized in the carrier matrix can be measured.

The substrates of the present invention have proven to be suitable for determining the activity of glucosidases of all origins. The diagnostic agents according to the invention, the substrates of which are of the general formula I, clearly react more sensitively than the hitherto known test substances.

The olycosides of the resorufin derivatives of the formula I are also suitable for immunological assays in which glycosidases are used as indicator enzymes, the activity of which must be reported after the immunological reaction has been carried out.

Such assay methods using an enzymatic indicator reaction are known to those skilled in the art as enzymatic immunoassays. These methods can be used to determine the concentration of proteins, polysaccharides, hormones, drugs and other low molecular weight substances in the concentration range -5-12 to 10-10 mol / l. Depending on whether the phase separation steps are necessary or not, there is talk of a homogeneous and heterogeneous performance of the experiment. Other subdivisions can still be made on the basis of competitive and non-competitive test principles.

However, all experimental principles work with enzyme-antigen or enzyme-antibody conjugates. The enzymatic indicator reaction is the same in all enzymatic immunoassays. Suitable indicator enzymes for this purpose are, for example, glycosidases, in particular β-D-galactosidase. The determination of these glucosidases in such enzymatic immunoassays is usually carried out by adding to the sample a suitable substrate which is enzymatically cleaved and which is usually measured photometrically or also fluorometrically.

Thus, the improvement of glycosidase assay systems also leads to significant advantages in such enzymatic immunoassays: 1. Better sensitivity also now allows further lowering of the detection limit, shorter reaction times and the use of smaller samples, and thus less interference from other components of the sample.

2. The more favorable wavelength used for the measurement reduces interference from insoluble constituents, such as turbidity, when using a particular reaction method in the method.

Such a diagnostic agent contains, in addition to one or more, a suitable buffer system of the general formula I and the substrate according to the invention, and optionally other suitable additives commonly used in such diagnostic agents, such as wetting agents, stabilizers, etc. This diagnostic agent may be in the form of a solution, lyophilisate, powder mixture. , as a reagent tablet or may be absorbed into an absorbent carrier.

The diagnostic agent of the invention in the form of a solution preferably contains all the reagents required for the test. Suitable solvents are water, or mixtures of water and a water-soluble organic solvent, such as, for example, methanol, ethanol, acetone or dimethylformamide. For reasons of preservation, it may be advantageous to divide the reagents required for the test into two or more solutions which are not mixed together until the actual test.

i7 81 359

In the form of a lyophilisate and each time a total of about 5 to 20 mg, preferably about 10 mg of diagnostic agent, a solution is prepared which contains all the reagents required for the test, including ordinary body builders such as polyvinylpyrrolidone, and optionally other excipients such as mannitol, sorbitol or xylitol.

The diagnostic agent in the form of a powder mixture or reagent tablets can be prepared by mixing the ingredients to be used in the test with conventional galenic additives and making this mixture into granules. Such additives include, for example, sugar alcohols such as mannitol, sorbitol or xylitol, or other soluble inert compounds such as polyethylene glycol or polyvinylpyrrolidone. Usually such powder mixtures or reagent tablets weigh about 30-200 mg, preferably 50-80 mg.

To prepare a diagnostic agent in the form of a test strip, an absorbent carrier, preferably a filter paper, cellulose or man-made fiber mat, is impregnated with volatile solvents such as water, methanol. with a solution of the reagents necessary for the preparation of such test strips in ethanol or acetone. This can be done in one impregnation step. However, it is often expedient to carry out this impregnation in several stages, using solutions which in each case contain one part of the constituents of this diagnostic substance. Thus, for example, in the first step it may be impregnated with an aqueous solution containing a buffer and other water-soluble additives, and then in the second step it is impregnated with a solution containing a glycosidase substrate. These finished kcepaoers can be used alone or can be glued to a substrate in a manner known per se or preferably attached in accordance with DBP 2 118 455 between plastic and small loop nets.

The following examples illustrate some of the numerous variations of this method that can be applied to the synthesis of the compounds of the invention 81359 and illustrate, by way of example, the use of novel glycosides of resorufin derivatives to determine glycosidase activity. However, these examples are not intended to limit the objects of this invention.

Example 1

Resorufin-3-D-galactocyanoside a) Preparation of resorufin

Resorufin is prepared from its oxidation product resosurin, which is commercially available in sufficient purity, based on the method of Niet zki et al. (Ber. Dtsch. Chem. Ges. 2_2 (1889) pages 3020-3038). Then 10 g (43 mmol) of resazuri.in (Fluka, Buchs, Switzerland) are heated in a beaker in a mixture of 50 ml of 25% ammonia solution, 25 ml of 37% sodium hydrogen solution and 50 ml of water for 30 minutes. in a boiling water bath. To this mixture are added an additional 20 mL of ammonia solution, 7 mL of hydrogen sulfide solution and 20 mL of water, and further heated for 30 minutes. The conversion can be detected by a change in color from blue to red or by thin layer chromatography. After the reaction is complete, 10 ml of 32% brine is added to the mixture until the pH is 5. This reaction solution. . let stand in the refrigerator for 24 hours. The brownish precipitate is then filtered off with suction, washed with ice-cold hydrochloric acid solution, pH 4, and dried at H0 ° C. Yield 7.8 g (35.7 mmol; 8%) of theory.

b) Glycosylation of resorufin by resorufin-β-D-actopyranoside See glycosylation of the phenolic hydroxyl group, with tetraacetate acting as intermediate, by the following method. A mixture prepared in 50 ml of methylene chloride comprising 2.13 g (10 mmol) of finely ground resorufin, 4.12 g (10 mmol) of acetobromo-α-D-ga lactose α (Sigma, Munich), 1.16 g (5 mmol) of silver I-oxide (Fluca, Buchs, Switzerland), 5 g of calcium sulphate (CaSO 4. 1/2 H 2 O; Drierite), a few iodine granules and 50 μl of quinoline are stirred at room temperature for 40 hours .

In this case, 40% of the resorufin is converted to resorufin O-D-galactopyranoside tetraacetate. The reaction can again be monitored by thin layer chromatography. After the solids have been separated by a crease filter and centrifugation, the methylene chloride is evaporated on a rotary evaporator. Resorufin β-D-ga1aktODyranoside tetraacetate remains in the container as a brownish-yellow syrup. The yield is about 2 g (35% of theory).

2 g of resorufin β-D-galactopyranose.di-tetraacetate are mixed without further purification with 80 ml of dry methanol. Dissolve 0.5 g of sodium in small pieces in an ice bath in 20 ml of dry methanol. 6-8 ml of this methoxide1 product are added in 30 ml portions over 30 minutes to a solution of resorufin-3-D-galactopyranoside tetraacetate in an ice bath and with stirring, and the deacetylation is monitored by thin layer chromatography. The precipitated orange resorufin S-D-galactopyranoside is filtered off with suction and washed with ice-cold methanol. The yield is about 1 g of crude substance (70% of theory). Recrystallization from methanol followed by drying (not above 60 ° C) gives 0.2 g of pure product. All thin-layer chromatographic studies to monitor the progress of the reaction may be carried out on a system using nickel (Kieselgel 60; Merck, Darmstadt 'and methylene chloride / methanol (9/1) as the mobile phase. In this system: the following Rf values apply:

Resorufin 0.4

Resazurin 0.35

Resorufin 3-D-galactopyranoside tetraacetate 0.9

Resorufin-6-D-galactopyranoside 0.1.

Example 2

Resorufin gD-glucoside 2.13 g (10 mmol) of resorufin (prepared according to Example 1a), 4.1 g (10 mmol) of acetobromo-α-glucose and 3.64 g (10 mmol) of hexadecyltrimethylammonium bromide are heated under reflux for 4 hours. comprising 11.5 ml of 1 N sodium hydroxide solution and 50 ml of chloroform. The mixture is then evaporated to dryness and mixed with ethyl acetate. This ethyl ester solution is evaporated to dryness again. It is dissolved in 20 ml of ethanol at 20 ° C. The tetraacetyl-resorufin-g-D-glucoside precipitated from this solution is recrystallized from methanol to which activated carbon is added.

For deacetylation, the substance is dissolved in 10 ml of methanol. After stirring for 2 hours at room temperature, the precipitated product is filtered off with suction and dried. Yield: 50 mg.

1 H-NMR (δ dc-DMSO): δ = 3.15 - 3.80 (m, 6H); - o 4.5 - 6.5 (broad, 4H); 5.12 (d, J = 6.9 Hz, 1 H); 6.29 (d, J = 2.0 Hz, 1 H); 6.80 (dd, J = 9.6 and 2.0 Hz, 1H); 7.12 (dd, J = 8.5 and 2.0 Hz, 1H); 7.16 (d, J = 2.0 Hz, 1 H); 7.55 (d, J = 9.6 Hz, 1 H); 7.80 (d, J = 8.5 Hz, 1 H).

Example 3

Resorufin-1-carboxylic acid methyl ester 50 g of nitrosoresorsine, 53.3 g of 3,5-dihydroxybenzoic acid methyl ester and 28.0 g of pyrolucite are dissolved or suspended in 500 ml of methanol. To this mixture, while cooling in an ice bath and at a temperature of 5-10 ° C, 34.4 ml of concentrated sulfuric acid are added dropwise. The ice bath is removed and the mixture is further fined for another two hours. Then, 200 ml of aqueous ammonia solution is added thereto, while cooling the mixture. The precipitated solid is filtered through a glass fiber filter. 10 g of zinc powder are added portionwise to the filtrate at 5-10 ° C. The mixture is stirred at room temperature until the reduction is complete (thin layer chromatographic detection, mobile phase 4: 1 ethyl acetate / methanol, reaction time about 1.5 hours). The mixture is evaporated on a rotary evaporator to 1/3 of the original volume at a bath temperature of 25 ° C. The desired product is precipitated by acidifying the mixture with concentrated hydrochloric acid until the color changes, cooling the mixture. After washing with dilute hydrochloric acid and drying in vacuo with calcium chloride, resorufin-i-carboxylic acid methyl ester is obtained. Yield: 30.9 g (36% of theory).

218139 1 H-NMR: (δ 76 -DMSO): δ = 3.98 (s, 3H); 6.47 (d, J = 2.2

Hz, 1H); 6.85 - 6.95 (m, 2H); 7.09 (d, J = 2.2 Hz, 1 H); 7.60 (d, J = 9.6 Hz, 1 H).

Fluorescence: absorption: A = 570 nm max emission: λ = 588 nm.

max

In a similar manner a) 3,5-dihydroxybenzoic acid and nitrosoresorcin, with resazurin-1-carboxylic acid as an intermediate, give resorphine-1-carboxylic acid, UV / VIS (0.1 M in potassium phosphate buffer, dH 7.5): λ = 569 nm ' max b) 4-Methoxy-resazurin-1-carboxylic acid methyl ester is obtained from 4-methoxy-resazurin-1-carboxylic acid methyl ester as intermediate 4-methoxy-resorufin-1-carboxylic acid methyl ester from 4-O-methyl-gallic acid methyl ester and nitrosoresorcinol, UV / VIS (0,1 M in potassium phosphate ratio, dH 7,5): '= 592 nm max c) 3,5-dihydroxybenzoic acid methyl ester and 4-chloro-6-nitrosoresorcin give 8-k 1o or ir esats When i-1-carboxylic acid methyl ester acts as an intermediate, 8-chloro-resorphine-1-carboxylic acid methyl ester d) 4-O-methyl-gallic acid methyl ester and 4-bromo-6-nitro-soresorcin give 8- bromo-4-methoxy-resazurin-1-carboxylic acid oo-methyl ester acting as an intermediate 8-bromo-4-methoxy resorcinol-1-carboxylate xylic acid methyl ester e) 5-nitroresorcinol and nitrosoresorcin are obtained with 1-nitro-resazurin as intermediate: 1 "nitro-resorufin: *" · f) resorcinol-5-sulfonic acid and nitrosoresorcine sulfonic acid.

22 81 359

Example 4

Resazurin-4-carboxylic acid 160 g (10.5 mmol) of nitrosorosine, 1.55 g (.10.0 mmol) of 2,6-dihydroxybenzoic acid and 0.86 g (10 mmol) of pyrrolucite are mixed with 20 ml of: methanol and cooled to 0 ° C. To this mixture is added dropwise 1.06 ml of concentrated sulfuric acid. It is stirred for a further 2 hours without cooling. The precipitated red product is filtered off, washed with methanol and dried. Yield: 2.3 g (85¾ of theory).

UV / VIS (0.1 M in potassium phosphate buffer, pH 7.5): Λ = 614 nm (e = 48 cm ^ mol "*") max

After acidification: λ = 522 nm (ε = 32 cm -1 mol ^) max

Example 5

Resorufin-4-carboxylic acid 2.3 g of resazurin-4-carboxylic acid (prepared according to Example 4) are dissolved in 20 ml of water and 5 ml of 25% ammonia. To this blue solution is added 5 g of zinc dust in an ice bath under cooling. The ice bath is then removed to gradually warm the solution to room temperature. The reduction can be easily detected as a color change from blue to dark purple, or it can be detected by thin layer chromatography (mobile phase: methanol / ethyl acetate 1: 1). Excess zinc powder is filtered off. The reaction solution is made ashamed with 5 ml of glacial acetic acid and concentrated hydrochloric acid. The precipitated product is filtered off, washed with dilute hydrochloric acid and dried in vacuo over calcium chloride. Yield: 1.8 g (82¾ of theory).

UV / VIS: (0.1 M in potassium phosphate buffer, pH 7.5): λ = 579.4 nm (e = 48.6 cm 2 mol - "* -); max

After acidification: λ = 485.9 nm (ε = 34.7 cm -1 mol ^). max ', Fluorescence: Absorption: λ = 579 nm ^ max

Emission: λ = 593 nm.

max 23 81 359

Example 6 1-Methylresorufin-4-carboxylic acid

In analogy to Example 4, 840 mg of 2,6-dihydroxy-4-methylbenzoic acid, 760 mg of nitrosoresorcin, 430 mg of pyrolucite and 0.53 ml of sulfuric acid are converted into 1-methylresazurine-4-carboxylic acid. Yield: 0.8 g. The 1-methylresazurine-4-carboxylic acid thus obtained is reduced analogously to Example 5 to 1-methylresorufin-4-carboxylic acid. Yield: 0.4 g.

UV / VIS (0.1 M in potassium phosphate buffer, oH 7.5): max - 571 nm.

Example 7

Resorufin-4-carboxylic acid morpholide 1) N, 0,0-triacetyldihydroresorufin-4-carboxylic acid Modification a) 5 g (19.4 mmol) of resorufin-4-carboxylic acid or 5.3 g (19.4 mmol) of resazurin-4- the carboxylic acid is heated under reflux for 0.5 hour in 100 ml of 10% hydrochloric acid containing 7 g (38 mmol) of stannous chloride a. This solution then turns green. The mixture is allowed to cool, the precipitated dihydroresorufin-4-carboxylic acid is filtered under a nitrogen atmosphere and dried in vacuo over phosphorus pentoxide. The crude product thus obtained is heated under reflux for 30 minutes with 30 ml of acetic anhydride and 20 mg of sodium acetate. The reaction mixture is poured into 200 ml of ice water and stirred for 14 hours. The solid is recrystallized from ethanol / water. 4.8 g (65%) of the desired compound are obtained.

Melting point: 197-199 ° C.

Thin layer chromatography (Kieselgel, eluent chloroform / methanol / glacial acetic acid, 9: 1: 0.1): = 0.33.

Modification b) 5.1 g (20 mmol) of resorufin-4-carboxylic acid are stirred in 20 ml of acetic anhydride containing 11 g (60 mmol) of stannous chloride for 1 hour at 80 ° C. The mixture is poured into 24 81 359 230 ml of ice water, stirred for 1 hour, filtered and treated analogously to variant a).

Yield: 5.4 g (71%).

2) Ν, Ο, Ο-Triacetylhydroresorufin-4-carboxylic acid chloride To 3.85 g (10 mmol) of N, O, O-triacetyldihydroresorufin-4-carboxylic acid is added 5.4 ml (60 mmol) of oxalyl chloride and the mixture is cooled to -10 °. C temperature. To this is added dimethylformamide and the reaction mixture is allowed to warm to room temperature with stirring. .1 aan. The decomposing product then dissolves, evolving gas. After gas evolution has ceased, the mixture is stirred for a further 0.5 hour, evaporated, dissolved three times in 20 ml of dry methylene chloride and evaporated to dryness.

This gives 4 g of crude product, which is further processed without further purification.

Thin layer chromatography (Kieselgel, chloroform / methanol / glacial acetic acid, 9: 1: 0.1 as eluent): = 0.42; a colorless blister that turns red after a few hours.

3) Ν, Ο, Ο-Triacetyldihydroresorufin-4-carboxylic acid morpholide 11.3 g (31.4 mmol) of crude acid chloride are dissolved in 150 ml of dry methylene chloride. To this is added 8.7 ml dropwise. . (63 mmol) triethylamine followed by 3.3 mL (37.7 mmol) morpholine. Stirring is continued for a further 2 hours, the solution is washed with 1% citric acid, sodium bicarbonate solution and water, the organic phase is dried over magnesium sulphate and evaporated. The residue is recrystallized from ethanol. Yield: 8.1 g (63%), melting point: 133-135 ° C (decomposes). 1

II

Resorufin-4-carboxylic acid morpholide 3.7 g (9 mmol) of triacetyldihydroresorufin-4-carboxylic acid morpholide are mixed with 250 ml of methanol and 250 ml of water. To this are added 36 ml of 1 N sodium hydroxide solution and 6.0 g (18 mmol) of potassium hexacyanoferrate (III), and the mixture is stirred for 14 hours at room temperature. After acidification to pH 3 with hydrochloric acid, the mixture is evaporated to dryness and stirred with acetone. This color solution is filtered through 500 ml of silica gel using acetone as eluent. After evaporation of the dye-containing eluate to dryness, 2.3 g (80%) of product are obtained.

UV / VIS (0.1 M in potassium phosphate buffer, pH 7.5): λ = 575 nm, ε = 55,000 cm -1 mol. max

Thin layer chromatography (eluent as in 2):

Rf = 0.52.

1 H-NMR 1 / h 7 -DMSO): δ = 3.3 - 3.8 (m, 8 H); 5.50 - b (d, J = 2 Hz, 1H); 6.64 (d, J = 10 Hz, 1H); 6.76 (dd, J = 10 and 2 Hz, 1H); 7.44 and 7.51 (d, J = 10 Hz, 2 H each).

Example 8

Tetraacetylresorufin-1-carboxylic acid methyl ester β-galactyranoside and tetraacetylresorufin-9-carboxylic acid methyl ester β-D-galactopyranoside 6.8 g of resorufin-1-carboxylic acid methyl ester (prepared according to Example 3) , 75 g of silver I-oxide, 6.75 g of hODeacarbonate, 15 g of 4 Å molecular sieves and 10 g of α-bromo-tetra-acetyl-galactose are stirred in 250 μl of absolute chloroform for 4 hours at room temperature. After further adding 5 g of α-bromo-tetraacetyl-galactose to this mixture, it is stirred overnight. The reaction mixture is filtered through a glass fiber filter and evaporated. The oily crude product is chromatographed on 2 l of silica gel using a 2: 1 mixture of chloroform / ethyl acetate as eluent. This gives 2.5 g of a yellow fraction of 0.28 (HPTCL-Kieselgel, same eluent). After stirring in methanol, the tetraacetyl resorufin-9-carboxylic acid methyl ester β-D-galactopyranoside is obtained as orange crystals. Yield 1.5 g.

26 81 359 1 H-NMR (d d76-DMSO): δ = 1.95, 2.03, 2.04 and 2.14 (s, 12 H each); 3.88 (s. 3H); 4.11 (d, J = 7Hz, 2H); 4.51 (t, J = 7 Hz, 2 H); 5.24 (m, 2H); 5.36 (m, 1 H); 5.69 (m, 1 H); 6.31 (d, J = 2Hz, 1H); 6.97 (d, J = 2 Hz, 1H); 7.04 (dd, j = 8.8 and 2.4 Hz, 1H); 7.14 (d, J = 2.4 Hz, 1 H); 7.78 (dd, J = 8.8 Hz, 1 H).

The same yellow fraction of 1.6 g of Rf is then eluted. is 0.24. Tetraacetyl-1-carboxylic acid methyl ester 3-D-galactopyranoside crystallizes from methanol as yellow-orange crystals. Yield: 1.2 g.

1 H-NMR (/ 57 -OMSO): δ = 1.95, 2.02, 2.04 and 2.14 (in each case - - 6 s, 12H); 3.90 (s, 3H); 4.09 (m. 2H); 4.51 (m, 1 H); 5.24 (d, J = 7Hz, 1H); 5.25 (m, 1 H): 5.36 (m, 1 H); 5.71 (m, 1 H); 6.50 (d, J = 2Hz, 1H); 6.83 (dd, J = 10 and 2 Hz,

1H): 7.20 and 7.24 (d, J = 2Hz, 2H each); 7.47 (d, J

(10 Hz, 1H).

A mixture fraction can still be eluted between these pure products, from which recrystallization in methanol gives 2.5 g of crystals of a mixture of both isomeric compounds.

In an analogous manner, α-bromotetraacetylgalactose and a) 2-methoxyresorpholine-1-carboxylic acid methyl ester give tetraacetyl-4-methoxyresorufin-1-carboxylic acid opa-methyl ester β-D-galactopyranoside and tetraacetyl -6-methoxy-resorufin-9-carboxylic acid methyl ester, β-D-galactopryanoside.

b) 8-Chloro-resorufin-1-carboxylic acid methyl ester gives tetraacetyl-8-chloro-resorufin-1-carboxylic acid methyl ester β-β-D-galactopyranoside and tetraacetyl-2-chloro- resorufin-9-carboxylic acid methyl ester-gD-galactopyranoside.

27 81 359

Example 9

Tetraacetyl-resorufin-4-carboxylic acid morpholide-3-D-galactopyranoside and tetraacetyl-resorufin-6-carboxylic acid morpholide-3-D-galactopyranoside 3.26 g (10 mmol) of resorufin-4-carboxylic acid morphine is galactosated analogously to Example 8. This crude product is chromatographed on 1 L of Kieselgel and 3: 1 ethyl acetate / acetone as the mobile phase. 0.9 g of tetraacetyl-resorufin-6-carboxylic acid morphide-g-D-galactopyranoside are thus obtained, thin layer chromatography (Kieselgel, mobile phase according to Example 7):

Rf = 0.71.

and 0.4 g of tetraacetylresorufin-4-carboxylic acid morpholide β-D-galactopyranoside by thin layer chromatography (Kieselgel, same mobile phase): R = 0.76 and 1.2 g of a mixture fraction of these two isomers.

Example 10

Resorufin-1-carboxylic acid methyl ester BD-galactopyranoside: 1.2 g of tetraacetylresorufin-9-carboxylic acid methyl ester-8-D-galactopyranoside are deacetylated in analogy to Example 2 with sodium methylate / methanol. mixture. Yield: 0.8 g.

UV / VIS (0.1 M in potassium phosphate buffer, pH 7.5): λ = 464 nm (c = 21.8 cm -1, mol ^). After digestion with max '' 3-galactosidase, the anion of resorufin-1-carboxylic acid methyl ester is obtained: λ = 572 nm (ε = 65.4 cm -1 mol- ""), max 1 H-NMR (δ7.-DMSO): δ = 3.20 - 3.80 (m, 6H), 3.91 (s,

- ”O

3H): 5.09 (d, J = 7.5 Hz, 1H): 6.30 (d, J = 2.1 Hz, 1H); 6.81 (dd, J = 9.8 and 2.1 Hz, 1H); 7.30 (m. 2H); 7.51 (d, J = 9.8 Hz, 1 H); OH protons very broad, about 5.

28 81 359

Analogous deacetylation of the corresponding tetraacetates gives a) resorufin-1-carboxylic acid methyl ester-BDc alto-olyranoside 1H-NMR ([D7C-DMSO]): δ = 3.4 - 3.7 (m, 6 H): δ, 09 (d, J = 7.5 Hz, 1H); 6.34 (d, J = 2 Hz, 1H): 6.97 (d, J = 2 Hz, 1H): 7.08 - 7.17 (m, 2H): 7.75 (d, J = 10 Hz, 1H); OH: very broad, about 5 ppm b) 4-Methoxy-resorufin-1-carboxylic acid o-methyl-ester-0-D-galactovranoside c) 6-Methoxy-resorufin-9-carboxylic acid methyl ester-BD-galactopryanoside d) 8 -chloro-resorufin, 1-carboxylic acid methyl ester-β-D-galactopyranoside e) 2-chloro-resorufin-9-carboxylic acid methyl ester-PD-galactopyranoside f) resorufin-6-carboxylic acid morphactoporpholide R ^. (ethyl acetate / isopropanol / water 9: 4: 2): 0.3.

After digestion with β-galactosidase: UV / VIS (0.1 M in potassium phosphate buffer, pH 7.5): λ = 574.6 nm max fluorescence emission: / = 593 nm max g) resorufin i-4-carboxylic acid morphoid-β-D -galakto-oyranosidia.

R (ethyl acetate / isopropanol / water 9: 4: 2): 0.3 after digestion with β-galactosidase: UV / VIS (0.1 M in potassium phosphate buffer, pH 7.5): λ = 574.6 nm, max fluorescence emission: λ = 593 nm.

max

Example 11

Resorufin-9-carboxylic acid β-D-galactopyranoside triethylammonium salt 266 mg of resorufin-9-carboxylic acid methyl ester β-D-galactopyranoside are mixed with 50 ml of water and 20 ml of 1,4-dioxane. To this is gradually added 5 ml of 0.1 N sodium hydroxide solution in 0.5 ml portions, whereby the pH of the solution must not rise above 12.5. The reaction mixture is poured onto 6 ml of DEAE-Sephadex resin in carbonate form. .

It is washed with 180 ml of water.

The product is then eluted with 0.1 M triethylammonium carbonate buffer, pH 7.5. The eluate is evaporated in vacuo. It is then evaporated several times with ethanol. Yield: 10 mg of resorufin-9-carboxylic acid S-D-galactopyranoside triethyl ammonium salt.

UV / VIS (0.1 M potassium phosphate buffer, pH 7.5): λ = 4 6 5 nm after digestion with max B-ga1actosidase11a: λ = 5 70 nm. max

Example 12

Resazurin-β-D-galactopyranoside 12.6 g of the sodium salt of resazurin are dissolved in 65 ml of 1 N sodium hydroxide solution and 80 ml of water. To this are added 20.6 g of acetobromo-α-D-galactose in 150 ml of chloroform and 18.2 g of hexadecyltrimethylammonium. . bromide. This mixture is heated at reflux for 3 hours. It is then evaporated to dryness and mixed with ethyl acetate. This ethyl acetate solution is evaporated again and chromatographed on 500 g of silica gel (eluent: methylene chloride / ethyl acetate 3: 1). 2.13 g of tetraacetylresazurine-6-D-galactopyranoside with an Rf value of 0.5 (HPTLC-Kieselgel, same mobile phase) are obtained.

To deacetylate, 2.13 g of the tetraacetyl derivative are stirred at room temperature for 1 hour in 100 ml of absolute methanol containing 0.1 g of sodium methylate. The precipitated product is filtered off with suction and dried in vacuo over calcium chloride. Yield: 1.0 g.

= 0.62 (HPTLC-Kieselgel, ethyl acetate / isopropanol / water 9: 4: 2).

30 81 359 1 H-NMR (δ B 7 -DMSO): δ = 3.30 - 3.90 (m, 6H); 4.54 (br.d, J = 4.4 Hz, 1 H); 4.67 (br. T, J = 4.4 Hz, 1 H); 5.07 (d, J = 7Hz, 1H); 5.27 (br. D, J = 4.4 Hz, 1H); 6.15 (d, J = 2Hz, 1H); 6.63 (dd, J = 9.6 and 2 Hz, 1H); 7.10 (dd, J = 9 and 2 Hz, 1 H); 7.2 (m. 2H): 7.96 (d, J = 9.6 Hz, 1H); 8.07 (d, J = 9Hz, 1H).

Example 13 8-Chloro-resaturine-4-carboxylic acid 4.3 g (30 mmol) of 4-chloro-resorcinol are dissolved in 20% ethanol. After adding 2.4 g of potassium hydroxide, the mixture is cooled to 5 ° C. 2.81 ml of isc-pentyl initriyl are added dropwise with cooling.

It is then further stirred overnight at room temperature. The solid is filtered, dissolved in water and acidified. The yellow precipitate is filtered off again and dried in vacuo at 40 ° C.

Yield: 2.5 a (48%) of 4-chloro-6-nitrosoresorcin.

R = 0.28 (HPTLC-Kieselgel, mobile phase: methanol / ethyl acetate 1: 3).

1.83 g of 4-chloro-6-nitrosoresorsine, 1.55 g of 2,6-dihydroxybenzoic acid, 0.86 g of pyrolucite and 1.06 ml of sulfuric acid are stirred in 20 ml of methanol and stirred for 2 hours at 0 [deg.] C. and 14 hours at room temperature. A red solid is obtained which is filtered and dried.

Yield: 2.45 g (80% of 8-chloro-resazurin-4-carboxylic acid.

UV / VIS (0.1 M in potassium phosphate buffer, pH 7.5): λ = 621.5 nm. max

Analogously a) 2-methyl-resorcinol gives 6-methyl-resazurin-4-carboxylic acid as an intermediate with 2-methyl-6-nitrosoresorcin;

II

3i 81359 b) 4-methyl-resorcinol gives 8-methyl-resazurin-4-carboxylic acid as an intermediate with 4-methyl-6-nitrosoresorcin; c) 4-Bromo-resorcinol gives 4-bromo-6-nitrosoresorcin as an intermediate 8-bromo-resazurin-4-carboxylic acid.

Example 14 8-Chloro-resorpholine-4-carboxylic acid 2 g of 8-chloro-resazurin-4-carboxylic acid (prepared according to Example 10) are dissolved in 20 ml of water and 5 ml of 25% ammonia. While cooling the mixture, zinc powder is added to it so that the color changes completely to a red belly braid. Excess zinc is filtered off. After acidification, the precipitated product is filtered off and dried in vacuo at 40 [deg.] C. with calcium chloride. Yield: 1.5 g (79%) of 8-chloro-resorufin-4-carboxylic acid.

UV / VIS (0.1 M in potassium phosphate buffer, pH 7.5): λ = 585.5 nm. max

Analogously a) 6-methyl-resazurin-4-carboxylic acid gives 6-methyl-resorufin-4-carboxylic acid; b) 8-methyl-resazurin-4-carboxylic acid gives 8-methyl-resorufin-4-carboxylic acid; c) 8-Bromo-resazurine-4-carboxylic acid is obtained from 8-bromo-resazurin-4-carboxylic acid.

Example 15

Resorufin-9-carboxylic acid methyl ester β-D-galactopyranoside To 3.9 g of pentaacetylgalactose is mixed with 0.1 g of anhydrous zinc chloride and boiled to 125 ° C. This is stirred for 20 minutes at 10 torr. To this melt is added 1 g of resorufin-1-carboxylic acid methyl ester. The mixture is stirred for 1 hour at 41 ° C, after which it is chromatographed on Kieselgel as described in Example 7 and using 32 81359 mobile phase 2: 1 chloroform / ethyl acetate as mobile phase.

Yield: 25 mg of tetraacetyl-resorufin-9-carboxylic acid methyl ester-α-D-galactopyranoside (yellow oil).

R ^. = 0.22 (HPTLC, Kieselgel, same mobile phase).

Deacetylation to resorufin-9-carboxylic acid methyl ester α-D-galactopyranoside is performed analogously to Example 10.

Example 16

Resorufin-9- (3,6-dioxaoctyl) -ester-BD-galactopryanoside To 0.6 g of tetraacetylresorufin-9-carboxylic acid methyl ester-6-D-galactopyranoside is added 50 ml of diethylene-fliccholide monoethyl. and a spatula tip of sodium hydride and this mixture is stirred for 15 minutes at room temperature.

100 ml of acetone are then added. The precipitated solid is filtered off and dried. Yield: 56 mg of resorufin-9-carboxylic acid (3,6-dioxooctyl) -ester-β-D-galactopyranoside.

= 0.54 (HPTLC, Kieselgel, mobile phase ethyl acetate / isopropanol 9: 4).

Example 17

Resorufin-maltoheptaoside

Amylase (E.C. 2.4.1.19), for example amylase from Bacillus macerais, has not only hydrolytic and cyclizing properties but also glycosyl group transfer properties which can be used in the synthesis of oligosaccharides and oligosaccharide derivatives (Methods in Carbohydrate Chemistry II.

680 mg of 'V amylase from Bacillus macerans DSM 24 (lyophilisate; weight 0.46 U / mg; protein content of this dose 28%), 500 mg of resorufin glucoside, 3.5 g of α-cyclodextrin and 70 ml of Soerensen phosphate buffer (pSH 6.2; 0.01 M) are mixed. This batch is incubated for 24 hours at 333 359 37 ° C. Thereafter, to simplify the mixture, the α- and the resulting β-cyclodextrin are separated as the inclusion compound of tetrachlorethylene. Chromatography with crosslinked dextran (Sephadex LH 20) gives 50 mg of reso-rufinyl maltoheptaoside lyophilisate, which is highly active in the amylase assay.

Example 18 Determination of β-D-galactosidase activity a) Preparation of the solutions used

Buffer solution: HEPES 100 mmol / l

Sodium chloride 154 mmol / l

Magnesium L-aspartate 2 mmol / l BSA 10 g / l

Tween-20 0.5 g / l pH (set with sodium hydroxide) 7.3 (37 ° C)

Reagent 1:

0.8 mmol / l reso-furine-3-D-ga1 actopyranoside is dissolved in the buffer solution described above.

Reagent solution 2:

3.5 mmol / l resorfufin-9-carboxylic acid β-D-galactopyranoside is dissolved in the buffer solution described above.

Reagent solution 3:. . 1.0 mmol / l resorufin-9-carboxylic acid methyl ester β-D-galactopyranoside is dissolved in the above buffer solution.

The enzyme solution

Commercially available 3-D-galactosidase from Escherichia coli is dissolved in the buffer solution described above. The activity of this solution is approximately 0.03 U / ml (according to the manufacturer's instructions).

34 81 359 b) Carrying out measurements

The measurement is performed photometrically at 579 nm.

950 ul of reagent is mixed in a 1 cm cuvette at 37 ° C with 50 ul of enzyme solution. The measure of the reaction is the increase in extinction per unit time, / mExt / min7 · It is calculated from the measured extinction by dividing it by the reaction time.

The following table shows the observed measurement results

Reagent no. Reaction / mExt / min7 1 85 2 46 3 76

Example 19 Detection of 3-D-galactosidase by means of an indicator film A homogeneous mass is prepared from the following ingredients: 5 ml of an aqueous solution of 0.5 M potassium phosphate and 0.05 M magnesium chloride, pH 7.3; 0.13 g sodium alginate; 8 g of a 50% dispersion of polyvinyl propionate 10 g of Kieselgel in 12 ml of water 0.4 g of Triton X-100 50 mg of resorufin-5-D-galactopyranoside dissolved in 5 ml of methanol.

This mass is applied to a 0.1 mm thick polycarbonate film (Pokalon, Fa. Lonza) with a gap width of 0.2 mm. This layer is dried at 50 ° C and then cut into 6x6 mm pieces. These are glued with adhesive tape over a 400 μm thick polystyrene film.

35 81 359 The test strips thus obtained are immersed briefly in the solution containing 3-D-galactosidase to be determined. After holding the strips for 2 minutes at room temperature, a red reaction color forms, the intensity of which depends on the concentration of β-D-galactosidase in the test solution. Test solutions with a known and known concentration of β-D-galactosidase can be used to provide a color scale from which the unknown concentration of β-D-galactosidase in a sample can be reported.

The test strips described above can also be used to determine the activity of β-D-galactosidase in a sample kinetically by reflection photometry. Also in this case, a standard curve is prepared in the usual way with samples from which the β-D-galactosidase activity of the samples is known, and this standard curve gives the unknown activity of the β-D-galactosidase in the sample.

Example 20

Determination of free and conjugated β-D-galactosidase activity a) Preparation of used solutions

Buffer solution: HEPES 100 mmol / l

Sodium chloride 154 mmol / l

Magnesium L-aspartate 2 mmol / l; BSA 10 g / l

Tween-20 0.5 g / l pH (set with sodium hydroxide) 7.3 (37 ° C)

The reagent solution:

0.8 mmol / l of reso-rutin-β-D-galactopyranoside is dissolved in the buffer solution described above.

Enzyme solution: Conventional commercially available β-D-galactosidase from Escherichia coli is dissolved in this buffer.

36 81359 The activity of this solution is approximately 0.08 U / ml (according to the manufacturer's instructions).

Enzyme Conjugate Solution A 3-D-galactosidase antibody preparation is used herein. The preparation of such enzyme-antibody conjugates is known. It is disclosed, for example, in Biochem. Biophys. Acta 612, 40-49 (1980). This preparation is diluted with buffer so that its activity is approximately comparable to the activity of the enzyme solution described above.

b) Carrying out the measurement

The measurement is performed photometrically at 578 nm.

950 [mu] l of reagent solution are each mixed in a 1 cm cuvette at 37 [deg.] C. with 50 [mu] l of enzyme solution or 50 [mu] l of enzyme-conjugate solution. The measure of the reaction is the increase in extinction per unit time, in _ / mExt / min_ /.

The reaction with free 3-D-galactosidase measures 85 mExt / min; The result of the reaction with the 3-D-galactosidase-antibody conjugate is measured to be 92 mExt / min.

Both measured values show that both free and conjugated β-galactosidase give a very well measurable difference in extinction.

It follows that the described compounds are similarly suitable as substrates for both the free glycosidase broth and the glycosidase conjugate. Thus, new substrates cannot be used as diagnostic agents alone to determine free glycosidases. They can also be used advantageously in immunoassay methods in which a glucosidase is used as an indicator enzyme.

Example 21 Determination of α-amylase activity

The filter paper is impregnated with reso-37 81 359 rufin-maltoheptaoside (prepared according to Example 17) dissolved in citrate buffer. The reagent paper thus obtained is successively placed in a sample containing α-amylase and α- and β-glucosidase. After a few minutes, a clearly visible red color can be observed, the intensity of which is proportional to the α-amylase content of the sample.

Samples containing known α-amylase levels can be used to prepare a standard curve from which the unknown α-amylase content of the sample can be determined.

The following abbreviations were used in the above examples: HEPES 2- [4- (2-hydroxyethyl) -1-piperazinyl] ethanesulfonic acid BSA Bovine Serum albumin

Tween 20 Polyoxyethylene (20) sorbitan monolaurate.

Claims (11)

1. In 11 db) C ^ ^ ^^ 0 0-- s- ^^, / S S S S S-O-Glycoside R2 R3 in which formulas 1a and 1b R ^ denote hydrogen, R4, R2 and R2, which may be the same or different, represents hydrogen, halogen or a lower alkyl group, R 3 and R 4, which may be the same or different, represent hydrogen, halogen, a cyano group, a lower alkyl group, a lower alkoxy group, a carboxy group, a lower alkoxycarbonyl group, a lower carboxyalkyl group, a lower-alkoxycarbonyl-lower-alkyl group or a possibly one or two-membered substituted carboxyamido group or the -C00- (CH2CH2O) n-R7 group, where R7 represents hydrogen or a lower alkyl group and n represents an integer of 1-4, wherein R 2 may further represent a sulfonyl or nitro group, and Y represents nitrogen or the group N - 0. Glycosides according to claim 1, characterized in that the glycoside residue represents a β-D-galactopyranoside, α D-galactopyranoside, β-D-glucopyranoside, aD-4 glucopyranoside or aD-mannopyranoside residue. 45 81 3 59 1. Glucosides of resorufin derivatives of the general formulas Ia or lb R1 R6 r2 r5 in | L L: ia) Glycoside-0 0 R1 2 R3 R1 R6 R2 Y 'v \ K <^ V \ v / ^ Glycosides according to claim 1, characterized in that the glycoside residue denotes an oligosaccharide having 2-10 monosaccharide units. 4. Process for Preparation of Glycosides of ResoruFin Derivatives of General Formulas Ia or Ib R1 R2 R3 Y R4 II (Ia) G1 y ko pd - 0 0 0 R5 R6 R1 R2 vvi ^ Y'R5 J 1 LI ( Ib) O-Glycoside R5 R6 which are glycosides Formulas Ia and Ib2 wherein R4 may further represent a sulfonyl or nitro group, R3 represents hydrogen, R3, R5 and R5 which may be the same or 4 lower carboxyalkyl group, a lower alkoxycarbonyl-lower-alkyl group or a possibly one or two-membered substituted carboxyamido group or the -COO-1C1 Cl2 O2 -R7 group, where R7 represents hydrogen or a lower alkyl group and n represents a group 1-4, 5, represents hydrogen, halogen or a lower alkyl group, R 6 and R 6, which may be the same or different, represent hydrogen, halogen, a cyano group, a lower alkyl group, a lower alkoxy group, a carboxy group, a lower alkoxycarbonyl group, a 7 and Y is nitrogen or the group N - 0, characterized in that compounds of the general tautomeric formulas Ha and Hb are R 1 R 6 R 2 R 5 'Y \ I / Wr'R5 ^^ II (lib) Ο'! Ii: \ r ^ '\ 0 R3 R4 wherein the symbols R ^ -R® and Y have the above by importance, is transferred in per se known manner to per-O-substituted glycosides with a mono- or oligosaccharide or a 1-halogeno derivative thereof, wherein in each case all hydroxy groups are substituted by a in the carbohydrate chemistry common protecting group, after which of these per-O-substituted glycosides, glycosides of resorufin derivatives of the general formulas Ia or 1b are obtained by cleavage of the protecting groups in a manner known per se. Use of glycosides of resorufin derivatives according to claim 1 or 2 for determining the activity of the corresponding glycosidases. Use of resorufin derivative glycosides according to claim 1 or 3 for determining the activity of digestive enzymes of saccharide chains. 7. Diagnostic agent for the detection of glycosidases containing one or more chromogenic and / or fluorogenic substrates, a suitable buffer substance and possibly other commonly used adjuvants, characterized in that, as chromogenic and fluorogenic substrates, glycosides of resorufin are used. derivatives according to claim 1 or 2. 8. Diagnostic agent for the detection of saccharide chain digesting enzymes, containing one or more chromogenic and / or fluorogenic substrates, a suitable buffer substance, possibly other commonly used adjuvants, a suitable glycosidase and possibly other auxiliary enzymes, known as having been characterized by and fluorogenic substrates use resorufin derivative glycosides according to claim 1 or claim 3. 9. Diagnostic agent according to claim 7 or 8, characterized in that auxiliary agents, galenic additives and / or steam forming agents are further used as auxiliary agents. 10. Resorufin derivatives of the general tautomeric formulas II'a and II'b R1 'R6' r2 'Sv \ r5' I (II'a) HO 0 r3 'r4' R1 'R6' ^ I (II ') b) O 2 OH R 3 'R 4' where R - * - 'represents hydrogen, R 2', R 3 'and R 2', which may be the same or different, represents hydrogen, halogen or a lower alkyl group, '81359 R 4' and R 2, which may be the same or different, represents hydrogen, halogen, a cyano group, a lower alkyl group, a lower alkoxy group, a carboxy group, a lower alkoxycarbonyl group, a lower carboxyalkyl group, a lower alkoxycarbonyl lower alkyl group or a lower alkyl group. possibly one or two-membered substituted carboxyamido group or the group -COO- (CH 2 CH 2 O) n - R 2, wherein R 2 represents hydrogen or a lower alkyl group and n represents an integer of 1-4, where R 1 '- R 6' are not all may simultaneously represent hydrogen, and Y represents nitrogen or the group N - 0, and wherein at least one of the groups R 4 'and R 2' represents a lower alkoxycarbonyl-, a possibly one or two-membered substituted carb -oxyamido group or the -COO-fCF 2 Cl 2 O 2 -R 2 group, where Y is nitrogen. 11. Use of Resorufin Derivatives of the General Tautomeric Formulas Ila and Lib R1 R6 r2 II I (Ha) Ho ^ wxo 0 R3 R4 R1 R6 _ ^ r5 ^ J I (nb) Represents OH, R3, R3 and R5, which may be the same or different, represent hydrogen, halogen or a lower alkyl group, R4 and R®, which may be the same or different, represent hydrogen, halogen, a cyano group, a lower alkyl group, a lower alkyloxy group, a carboxy group, a lower alkoxycarbonyl group, a lower carboxyalkyl group, a lower-alkoxycarbonyl-lower-alkyl group or a possibly one or two-membered substituted carboxyamido group or the group - COO- (CH2CH2O) nR4, where R4 represents hydrogen or a lower alkyl group and n represents an integer of 1-4, wherein further may represent a sulfonyl or nitro group, and Y represents nitrogen or the group N - 0, for preparation of resorufin glycosides according to claim 1 or 2.